News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,676 Results
Type
Article (8072)
Company Profile (141)
Press Release (479463)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166784)
Career Advice (304)
Deals (25745)
Drug Delivery (7)
Drug Development (52879)
Employer Resources (14)
FDA (9762)
Job Trends (8575)
News (238253)
Policy (17925)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (495)
Accelerated approval (29)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33159)
ALS (117)
Alzheimer's disease (993)
Antibody-drug conjugate (ADC) (312)
Approvals (10464)
Artificial intelligence (354)
ASCO (160)
Autoimmune disease (233)
Automation (33)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (29)
BIOSECURE Act (1)
Biosimilars (123)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (12)
Bladder cancer (142)
Brain cancer (34)
Breast cancer (534)
Cancer (3931)
Cardiovascular disease (235)
Career advice (245)
Career pathing (1)
CAR-T (184)
CDC (1)
CDMO (28)
Celiac Disease (3)
Cell therapy (506)
Cervical cancer (36)
Clinical research (48348)
Collaboration (1343)
Commercialization (20)
Compensation (1605)
Complete response letters (36)
COVID-19 (768)
CRISPR (68)
C-suite (846)
Cystic fibrosis (89)
Data (6228)
Denatured (4)
Depression (108)
Dermatology (95)
Diabetes (377)
Diagnostics (4249)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (168)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (174)
Earnings (73869)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88574)
Executive appointments (733)
Eye disease (3)
FDA (12646)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (990)
Gene editing (131)
Generative AI (13)
Gene therapy (347)
GLP-1 (307)
Government (955)
Grass and pollen (2)
Guidances (281)
Healthcare (9385)
Hematology (94)
HIV (56)
Huntington's disease (25)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (74)
Immunology and inflammation (113)
Immuno-oncology (67)
Indications (177)
Infectious disease (969)
Inflammatory bowel disease (140)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (270)
Interviews (41)
IPO (12399)
IRA (2)
Job creations (1971)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (67)
Layoffs (59)
Legal (5215)
Licensing (41)
Liver cancer (46)
Longevity (23)
Lung cancer (566)
Lung diease (8)
Lymphoma (266)
Machine learning (29)
Management (3)
Manufacturing (611)
Marketing (17)
MASH (121)
Medical affairs (2)
Medical device (8708)
Medtech (8884)
Mergers & acquisitions (14451)
Metabolic disorders (761)
mRNA (70)
Multiple sclerosis (110)
Multispecific (2)
NASH (4)
Netherlands (1)
Neurodegenerative disease (239)
Neuropsychiatric disorders (40)
Neuroscience (1922)
Neurotech (2)
NextGen: Class of 2026 (3152)
Non-profit (848)
Obesity (239)
Opinion (10)
Ovarian cancer (176)
Pain (186)
Pancreatic cancer (226)
Parkinson's disease (216)
Partnered (12)
Patents (522)
Patient advocacy (2)
Patient recruitment (547)
Patient selection (33)
Peanut (33)
People (41521)
Peptides (13)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15601)
Phase 2 (21601)
Phase 3 (14577)
Pipeline (8266)
Policy (18)
Postmarket research (1570)
Preclinical (6583)
Press Release (34)
Prostate cancer (202)
Psychedelics (10)
Radiopharmaceuticals (203)
Rare diseases (620)
Real estate (3025)
Recruiting (6)
Regenerative medicine (11)
Regulatory (15153)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (46)
RNA editing (8)
RSV (49)
Schizophrenia (109)
Series A (173)
Series B (126)
Service/supplier (5)
Sickle cell disease (65)
Spinal muscular atrophy (92)
Sponsored (6)
Startups (2022)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (54)
Tariffs (1)
Vaccines (347)
Venture capital (17)
Weight loss (77)
Wet AMD (3)
Women's health (97)
Date
Today (78)
Last 7 days (384)
Last 30 days (1581)
Last 365 days (19149)
2026 (15225)
2025 (19251)
2024 (22987)
2023 (26538)
2022 (34589)
2021 (37172)
2020 (33477)
2019 (23274)
2018 (17476)
2017 (18781)
2016 (17930)
2015 (24271)
2014 (21683)
2013 (18137)
2012 (20224)
2011 (20440)
2010 (20332)
Location
Africa (233)
Alabama (80)
Alaska (2)
Arizona (318)
Arkansas (12)
Asia (18033)
Australia (2118)
California (12784)
Canada (3340)
China (565)
Colorado (523)
Connecticut (444)
Delaware (222)
Europe (24781)
Florida (1921)
Georgia (405)
Hawaii (3)
Idaho (46)
Illinois (764)
India (58)
Indiana (330)
Iowa (18)
Japan (446)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1266)
Massachusetts (8361)
Michigan (321)
Minnesota (590)
Mississippi (4)
Missouri (84)
Montana (20)
Nebraska (11)
Nevada (132)
New Hampshire (60)
New Jersey (2815)
New Mexico (12)
New York (2995)
North Carolina (1356)
North Dakota (4)
Northern California (6468)
Ohio (302)
Oklahoma (14)
Oregon (17)
Pennsylvania (2377)
Puerto Rico (24)
Rhode Island (30)
South America (409)
South Carolina (80)
South Dakota (1)
Southern California (5325)
Tennessee (128)
Texas (2110)
United States (41427)
Utah (389)
Vermont (1)
Virginia (165)
Washington D.C. (39)
Washington State (983)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
487,676 Results for "retrophin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Biotech Beach
Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.
Retrophin Inc., (NASDAQ: RTRX) today announced that the Company has changed its global corporate name to Travere Therapeutics, Inc. This new name reflects the Company’s steadfast dedication to helping people
November 16, 2020
·
7 min read
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
Biotech Beach
Retrophin to Present at Upcoming Investor Conferences - Nov 11, 2020
Retrophin, Inc. announced that Company management will present at the following upcoming virtual investor conferences in November and December
November 11, 2020
·
1 min read
Biotech Beach
Retrophin Announces Proposed Public Offering of Common Stock
Retrophin, Inc. (Nasdaq: RTRX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering, subject to market and other conditions. All of the shares are being offered by Retrophin
June 8, 2020
·
3 min read
Business
Retrophin Reports First Quarter 2020 Financial Results
Retrophin, Inc. reported its first quarter 2020 financial results and provided a corporate update.
May 11, 2020
·
15 min read
Biotech Beach
Retrophin to Present at Upcoming Investor Conferences - Aug 03, 2020
Retrophin, Inc. announced that Company management will participate in the following upcoming virtual investor conferences in August
August 3, 2020
·
1 min read
Biotech Beach
Retrophin Announces Pricing of Public Offering of Common Stock
Retrophin, Inc. (Nasdaq: RTRX) today announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a price to the public of $15.50 per share. All of the shares are being sold by Retrophin.
June 8, 2020
·
4 min read
Biotech Beach
Retrophin to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the BMO 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020 at 10:00 a.m. ET. A live webcast of the presentation will be available at http://ir.retrophin.com/events and an archived replay will be accessible for up to 30 days. About Retrophin Retrophin is a biopharmaceutical company specializing in identif
June 19, 2020
·
1 min read
Business
Retrophin to Report Second Quarter 2020 Financial Results
Retrophin, Inc. (NASDAQ: RTRX) today announced it will report second quarter 2020 financial results on Thursday, July 30, 2020 after the close of the U.S. financial markets.
July 16, 2020
·
1 min read
1 of 48,768
Next
